Paper - WANFANG MED ONLINE

You Position: Home > Paper

腹腔热灌注化疗治疗腹膜假性黏液瘤的现状

( views:297, downloads:172 )

Author:: No author available

Journal Title:: CHINESE JOURNAL OF BIOMEDICAL ENGINEERING

Issue:: 3

DOI:: 10.3760/cma.j.issn.1674-1927.2010.03.024

Key Word:: No keyword available

Abstract： @@ 腹腔热灌注化疗(intraperitoneal hyperthermic perfusion chemotherapy,IHPC)可以清除肿瘤切除术后腹腔内残存的病灶,预防与治疗恶性肿瘤腹腔种植性转移,临床应用取得了满意的疗效[1].传统的细胞减瘤术(cytoreductive surgery,CRS)对腹膜假性黏液瘤(pseudomyxoma peritonei,PMP)的疗效不尽人意[2].如何在CRS术后彻底清除腹腔内残存的PMP活性细胞是预防PMP术后复发、提高患者长期生存率、改善患者预后的关键.现将CRS术后应用IHPC治疗PMP的临床应用现状作一综述.

Reference

[1]Tommaso Cioppa,Marco Vaira,Camilla Bing,etc.Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomixoma peritonei[J].2008,(44).
[2]刘玉林,陈宪,张照喜,等.腹膜假性黏液瘤的影像学表现[J].2005,(1).
[3]S, González-Moreno,P H, Sugarbaker.Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding.[J].2004,91(3).
[4]Baratti D,Allaria B,Andreola S,etc.Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei.[J].2004,11(4).
[5]Klempnauer J,Piso P,Schmidt U,etc.Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.[J].2005,20(2).
[6]Chang D,Sugarbaker PH.Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.[J].1999,6(8).
[7]P H, Sugarbaker.Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.[J].1900,87.
[8]陈凤媛,徐希岳.原发性腹膜假性粘液瘤-附1例报道和文献复习[J].2000,(1).
[9]Stewart-JH 4th,Shen P,Russell GB,etc.Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.[J].2006,13(5).
[10]Lersch C,Ott R,Frimberger E,etc.Gray-scale sonographic findings in a patient with pseudomyxoma peritonei.[J].2001,29(3).
[11]Ciaccio B,De-Simone M,Vaira M,etc.Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion.[J].2006,20(6a).
[12]Loggie BW,Jackson SL,Bechtold RE,etc.CT appearance of disseminated peritoneal adenomucinosis.[J].2001,26(4).
[13]P H, Sugarbaker.Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.[J].1994,219.
[14]Baratti D,Kusamura S,Nonaka D,etc.Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.[J].2009,249(2).
[15]Martinetti A,Oliva DG,Kusamura S,etc.Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.[J].2007,14(8).
[16]Sugarbaker PH.New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?[J].2006,7(1).
[17]Smeenk RM,Verwaal VJ,Zoetmulder FA.Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.[J].2006,32(2).
[18]J S, Spratt,R A, Adcock,M, Muskovin,etc.Clinical delivery system for intraperitoneal hyperthermic chemotherapy.[J].1980,40.
[19]Levy AD,Pickhardt PJ,Rohrmann CA Jr,etc.Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation.[J].2003,23(3).